Stephanie Routley

Research Scientist


Stephanie is a Research Officer within the Burnet Diagnostics Initiative.

She has a background in infectious disease laboratory research, centring on priority pathogens in low- and middle-income countries (LMICs) and viral pathogens with pandemic potential.

While completing her postgraduate degree in Medical Microbiology at the London School of Hygiene and Tropical Medicine (LSHTM), Stephanie studied potential drug targets in the multidrug-resistant bacterium Acinetobacter baumannii.

She later joined the National Institute for Biological Standards and Control (NIBSC), within the Medicines and Healthcare products Regulatory Agency (MHRA), in London, UK. As part of the Emerging Virus Group, she focussed on the development of serological and molecular International Standards for emerging and re-emerging viral pathogens Rift Valley Fever virus, Crimean-Congo Haemorrhagic Fever virus, SARS-CoV-2, Dengue virus 1-4 and Marburg virus.

Stephanie joined the Burnet in May 2022.


  • 2019: MSc (Medical Microbiology), London School of Hygiene and Tropical Medicine, UK
  • 2016: BSc, Australian National University, Australia
  • 2016: BA, Australian National University, Australia